Welcome to LookChem.com Sign In|Join Free

CAS

  • or
8-Chloroquinazolin-4(1H)-one is a chemical compound that belongs to the quinazolinone class, characterized by the presence of a chlorine atom at the 8th position on the quinazolinone ring. As a derivative of quinazoline, it exhibits various biological activities and has been studied for its potential medicinal properties, such as antitumor and anti-inflammatory effects. The chlorine substitution influences the compound's pharmacological properties, making it a promising candidate for drug development and a subject of interest in chemical and biological research.

101494-95-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 101494-95-5 Structure
  • Basic information

    1. Product Name: 8-CHLOROQUINAZOLIN-4(1H)-ONE
    2. Synonyms: 8-CHLOROQUINAZOLIN-4(1H)-ONE;8-chloroquinazolin-4(3H)-one;8-chloroquinazolin-4-ol
    3. CAS NO:101494-95-5
    4. Molecular Formula: C8H5ClN2O
    5. Molecular Weight: 180.59
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 101494-95-5.mol
  • Chemical Properties

    1. Melting Point: 302℃
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.50±0.1 g/cm3 (20 ºC 760 Torr)
    6. Refractive Index: N/A
    7. Storage Temp.: Sealed in dry,Room Temperature
    8. Solubility: N/A
    9. CAS DataBase Reference: 8-CHLOROQUINAZOLIN-4(1H)-ONE(CAS DataBase Reference)
    10. NIST Chemistry Reference: 8-CHLOROQUINAZOLIN-4(1H)-ONE(101494-95-5)
    11. EPA Substance Registry System: 8-CHLOROQUINAZOLIN-4(1H)-ONE(101494-95-5)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 101494-95-5(Hazardous Substances Data)

101494-95-5 Usage

Uses

Used in Pharmaceutical Development:
8-Chloroquinazolin-4(1H)-one is used as a potential drug candidate for its antitumor and anti-inflammatory activities. The chlorine substitution may enhance its pharmacological properties, making it a valuable compound for the development of new pharmaceutical drugs.
Used in Chemical and Biological Research:
8-Chloroquinazolin-4(1H)-one is utilized in various chemical and biological research studies due to its unique structure and biological activities. Researchers and scientists explore its potential applications in understanding the mechanisms of action, developing new drug targets, and discovering novel therapeutic agents.

Check Digit Verification of cas no

The CAS Registry Mumber 101494-95-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,1,4,9 and 4 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 101494-95:
(8*1)+(7*0)+(6*1)+(5*4)+(4*9)+(3*4)+(2*9)+(1*5)=105
105 % 10 = 5
So 101494-95-5 is a valid CAS Registry Number.

101494-95-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name 8-chloro-1H-quinazolin-4-one

1.2 Other means of identification

Product number -
Other names Kinome_3256

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:101494-95-5 SDS

101494-95-5Relevant articles and documents

Acceptorless Dehydrogenative Coupling of o-Aminobenzamides with the Activation of Methanol as a C1 Source for the Construction of Quinazolinones

Li, Feng,Lu, Lei,Liu, Pengcheng

, p. 2580 - 2583 (2016)

A strategy for the synthesis of quinazolinones via acceptorless coupling of o-aminobenzamides with methanol has been accomplished in the presence of the metal-ligand bifunctional catalyst [Cp?Ir(2,2′-bpyO)(H2O)]. Notably, this research exhibited the potential of transition-metal-catalyzed activation of methanol as a C1 source for the construction of heterocycles.

Synthesis and SAR optimization of quinazolin-4(3H)-ones as poly(ADP-ribose)polymerase-1 inhibitors

Kulkarni, Shridhar S.,Singh, Satyakam,Shah, Janki R.,Low, Woon-Kai,Talele, Tanaji T.

, p. 264 - 273 (2012)

We have demonstrated that quinazolin-4(3H)-one, a nicotinamide (NI) mimic with PARP-1 inhibitory activity in the high micromolar range (IC50 = 5.75 μM) could be transformed into highly active derivatives with only marginal increase in molecular weight. Convenient one to two synthetic steps allowed us to explore extensive SAR at the 2-, and 5- through 8-positions of the quinazolin-4(3H)-one scaffold. Substitutions at the 2- and 8-positions were found to be most favorable for improved PARP-1 inhibition. The amino group at 8-position resulted in compound 22 with an IC50 value of 0.76 μM. Combination of the 8-amino substituent with an additional methyl substituent at the 2-position provided the most potent compound 31 [8-amino-2-methylquinazolin- 4(3H)-one, IC50 = 0.4 μM] in the present study. Compound 31 inhibited the proliferation of Brca1-deficient cells with an IC50 value of 49.0 μM and displayed >10-fold selectivity over wild type counterparts. Binding models of these derivatives within the active site of PARP-1 have further supported the SAR data and will be useful for future lead optimization efforts.

Method of synthesizing quinazolinone derivative by using methanol as raw material

-

Paragraph 0075; 0076; 0077; 0078, (2017/12/06)

The invention discloses a method of synthesizing a quinazolinone derivative by using methanol as a raw material. The method comprises adding an anthranilamide derivative II, methanol III and an iridium metal complex in a reaction container; performing a reaction on the reaction mixture in a microwave reactor or under magnetic stirring at a temperature of 130 +/- 10 DEG C for 2 hours or more; performing cooling to a room temperature; removing a solvent in a spin drying manner; and performing column separation to obtain a target compound. The method provided by the invention adopts nontoxic and renewable methanol as a raw material, and the by-products in the reaction are hydrogen gas and water, thus the method does not pollute the environment and meet the requirements of green chemistry, so that the method has a wide development prospect.

POLAR QUINAZOLINES AS LIVER X RECEPTORS ( LXRS ) MODULATORS

-

Page/Page column 50, (2010/07/10)

Disclosed are polar quinazoline-based modulators of Liver X receptors (LXRs) and related methods. The modulators include compounds of formula (I): INSERT FORMULA HERE AS IT APPEARS IN WRITTEN FORM IN THE SPECIFICATION (I) in which, R1, R2, R3, R4, R5, R6,

Quinazoline Compounds

-

Page/Page column 36, (2010/12/26)

Disclosed are quinazoline-based modulators of Liver X receptors (LXRs) and related methods. The modulators include compounds of formula (I): in which R1, R2, R3, R4, R5, R6, R7,

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 101494-95-5